The incidence of bladder tumours in workers in the dyestuffs industry was first described by Rehn in 1895 and 1906 . Leuenberger reported 41 cases in 1912 , and by the third decade of this century in Europe exposure to beta naphthylamine and to benzidine had been accepted as a cause of bladder tumours by Kennaway (1924) , Berenblum and Bonser (1937) , Goldblatt (1949) , and Muller (1951) . In the U.S.A. Gehrmann, Foulger, and Fleming (1949) are less certain of the carcinogenicity of benzidine than the European investigators and have suggested that it cannot be accepted as a bladder carcinogen until it is known that benzidine workers without any exposure to beta naphthylamine have developed tumours of the bladder. This paper describes 23 cases of papilloma and carcinoma of the bladder among workers exposed only to benzidine, and reviews in all 66 cases not previously reported of confirmed bladder tumours arising in a dyestuffs factory. Fifty-eight cases were found in the section where intermediates are manufactured and eight in the colour factory where the intermediates are handled. No cross transfers have taken place and the populations have remained distinct. Only the men for whom data are complete have been included in this series. In addition there are 11 former employees believed to have died of bladder tumour whose histories are not yet fully traced, and two men reported to have developed tumours with whom contact has been temporarily lost. A voluntary system of compensation, by ex gratia payments, should help to ensure that the histories of men who develop tumours after leaving the factory will be known.
Manufacture of Intermediates In Table 1 it will be seen that of the 58 patients 19 have died. All except three of these 58 patients have been employed in the manufacture of benzidine, * A summary of this paper was read at the Tenth International Congress of Industrial Medicine, Lisbon, September, 1951. One case, which might be attributed to alpha naphthylamine in the manufacture of intermediates, developed a tumour after being employed for 18 years in the manufacture of naphthionate of soda from alpha naphthylamine. During this process a distillation residue containing about 170% of beta naphthylamine (from the 4%' beta impurity) was recovered as a molten product, set in trays, broken up by hand, and transferred to casks. It has previously been suggested by other investigators (Goldblatt, 1949; Muller, 1951) that the beta naphthylamine impurity in alpha naphthylamine is the causative factor in tumour production, and this man was, owing to the nature of the process, more heavily exposed to the residue with a high beta naphthylamine content than to technical alpha naphthylamine.
Aniline.-The manufacture of aniline by the iron reduction process started before 1900 of the boiler fireman, was four years and the longest 32 years, with an average of 16 years for all the manufacturing group. The latent period (Fig. 3) , that is the time from starting work to diagnosis of tumour, showed no appreciable difference between the 23 benzidine cases with a range of eight to 32 years (average 15-9 years) and the beta napthylamine cases with a range of five to 27 years (average 15 5 years). The 20 mixed and other exposures with a range of seven to 22 years tended on the whole to appear earlier but their average latent period was 16 years (Fig. 3) .
It is worth noting that, of the men exposed to beta naphthylamine who developed tumour, the one with the longest latent period (27 years' exposure) was the only chemist in the series. As a chemist he would have had considerably less exposure than a process worker.
Handling of Intermediates All of the eight cases reported in the colour factory have arisen among men who have worked on diazotization processes in colour synthesis. Seven have handled benzidine, and one both benzidine and alpha naphthylamine with the former as the major exposure. There have been no deaths among these men (Table 3) . This factory, which opened in 1919, has used benzidine in one building and small amounts of alpha naphthylamine in another. The amount of benzidine used has increased eightfold over the past 31 years and has utilized practically the whole output from the intermediates section. Special precautions were extended in this factory at about the same time that cases arose among men manufacturing intermediates, but the first case did not arise in the colour factory until 1941. Since then only one man at a time has been Types of Tumour.-Of the 58 cases, 29 had papilloma, 25 had carcinoma, and four had papilloma which recurred as carcinoma (Table 2 ). There is no striking difference in the incidence of benign and malignant tumours in the varying types of exposure in these small numbers, except that the men with mixed exposures had a higher proportion of carcinomata than other groups.* * The pathology and treatment of these tumours will be the subject of another paper n collaboration with Mr. Poole-Wilson. handling and charging benzidine. The three men so employed consecutively have been volunteers. The first, who had 14 years' previous exposure to benzi- is not yet applied, routine examination of the urine for red and white blood cells is done on all workers monthly. But with the possibility of such a high morbidity and early mortality arising from these processes more radical measures were deemed to be essential. Delayed by the war with its greater priorities, a new benzidine plant in which all possible precautions are taken to obviate contact between the operator and the carcinogens has now been built on a new site and will be in production this year. The old plant will be pulled down. Apart from a small number of key men, whose experience is needed and who will be selected from those who have had tumours and are cured, new men from the older age groups, with no previous exposure, will be selected and trained for this job. Thus, should any of these new men develop tumours it will be possible to attribute them solely to exposure on this plant when assessing the incidence.
Beta naphthylamine manufacture ceased a year and a half ago, as soon after the war as technical exigencies permitted, and sulphonation of beta naphthol followed by amidation is now the method used for preparing beta naphthylamine sulphonic acids in the synthesis of the colours for which beta naphthylamine was previously used as an intermediate.
In the future it should be possible to know whether or not these hazards have been controlled, but the time necessary for the development of tumours may be so long that we cannot be sure that the problem has been mastered until a whole generation has been unaffected. A The methods and history of manufacture and handling are described.
Of the 66 cases there were 30 (23 in the manufacturing section and seven in the handling section) whose exposure was to benzidine, and which had never been exposed to beta naphthylamine. Benzidine is therefore considered to be as dangerous a carcinogen, industrially, as beta naphthylamine.
The role of beta naphthylamine as a bladder carcinogen in manufacture and experimentally has previously been accepted, and 15 cases are attributed to it alone and others to mixed exposures. Beta naphthylamine as an impurity cannot be eliminated as a cause of bladder tumours in men who worked on alpha naphthylamine.
No cases have been traced which can be attributed to aniline, despite the longer time of manufacture and periods of exposure, and the similar numbers engaged on it compared with benzidine and beta naphthylamine.
Three other exposures are described in which the cause of tumour was doubtful or unknown.
Exposure, latent periods, and ages at diagnosis and death are discussed.
Men under the age of 30 should not be employed in the manufacture or handling of substances known or suspected to be bladder carcinogens and, when possible, healthy men over 40 should be employed on these processes.
